ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, D.S.
Right arrow Articles by Chung, K.F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, D.S.
Right arrow Articles by Chung, K.F.
Eur Respir J 2003; 22:478-483
Copyright ©ERS Journals Ltd 2003


Systematic assessment of difficult-to-treat asthma

D.S. Robinson1, D.A. Campbell2, S.R. Durham3, J. Pfeffer2, P.J. Barnes4 and K.F. Chung4 for the Asthma and Allergy Research Group of the National Heart and Lung Institute

1 Depts of Allergy, 3 Upper Respiratory Medicine, 4 Thoracic Medicine, National Heart and Lung Institute, Faculty of Medicine, Imperial College and 2 Royal Brompton and Harefield NHS Trust, London, UK

CORRESPONDENCE: D.S. Robinson, Dept of Allergy and Clinical Immunology, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, Dovehouse Street, London, SW3 6LY, UK. Fax: 44 2073518135. E-mail: d.s.robinson@imperial.ac.uk

Keywords: adherence, diagnosis, psychiatry, severe asthma

Received: February 14, 2003
Accepted May 23, 2003

D.A. Campbell is funded by the Joint Research Committee of the Royal Brompton and Harefield Trust and National Heart and Lung Institute. D.S. Robinson was funded in part by the Wellcome Trust.

Five per cent of asthmatics remain symptomatic despite high-dose treatment. The aim of the study was to investigate how often such difficult-to-treat asthma is due to intractable asthma, misdiagnosis, non-adherence with therapy, or psychiatric problems.

Difficult asthma was defined as persistence of symptoms despite treatment at step 4 of British guidelines or requirement for long-term oral glucocorticoids (step 5). One-hundred patients with a respiratory physician diagnosis of asthma were investigated in a single tertiary respiratory unit in an open and descriptive study.

Twelve of the patients studied did not have asthma and a further seven had additional diagnoses. Of the remainder, 55 had an asthma diagnosis confirmed by demonstration of reversible airflow narrowing or peak flow variability, whilst 20 did not. Noncompliance with prednisolone therapy was more frequent in the 55 with confirmed asthma (nine of 18 prescribed oral prednisolone at a dose of ≥15 mg·day–1) and was not detected in the "unconfirmed asthma" group. There were no other significant differences between these groups. A major psychiatric component was detected in 10 patients.

Systematic evaluation of difficult asthma is useful as it can identify alternative or additional diagnoses, psychiatric illness or nonconcordance with therapy in a substantial proportion of cases (32% in the present series).




This article has been cited by other articles:


Home page
ThoraxHome page
P Bhavsar, M Hew, N Khorasani, A Torrego, P J Barnes, I Adcock, and K F Chung
Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma
Thorax, September 1, 2008; 63(9): 784 - 790.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
R C Reddy
Severe asthma: approach and management
Postgrad. Med. J., March 1, 2008; 84(989): 115 - 120.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
M. R. Partridge
Examining the unmet need in adults with severe asthma
Eur. Respir. Rev., September 1, 2007; 16(104): 67 - 72.
[Abstract] [Full Text] [PDF]


Home page
DTBHome page
{blacktriangledown}Omalizumab for severe asthma?
DTB, November 1, 2006; 44(11): 86 - 88.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. Chanez and P. Godard
Is difficult asthma still clinically meaningful?
Eur. Respir. J., November 1, 2006; 28(5): 897 - 899.
[Full Text] [PDF]


Home page
Eur Respir JHome page
N. J. Roberts, D. S. Robinson, and M. R. Partridge
How is difficult asthma managed?
Eur. Respir. J., November 1, 2006; 28(5): 968 - 973.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
C. Butler and L. G. Heaney
Risk factors of frequent exacerbations in difficult-to-treat asthma.
Eur. Respir. J., June 1, 2006; 27(6): 1324 - 1325.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. E. Strek
Difficult asthma.
Proceedings of the ATS, January 1, 2006; 3(1): 116 - 123.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. ten Brinke, P. J. Sterk, A. A. M. Masclee, P. Spinhoven, J. T. Schmidt, A. H. Zwinderman, K. F. Rabe, and E. H. Bel
Risk factors of frequent exacerbations in difficult-to-treat asthma
Eur. Respir. J., November 1, 2005; 26(5): 812 - 818.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. N. R. Payne and A. Bush
"Refractory" Eosinophilic Airway Inflammation in Severe Asthma
Am. J. Respir. Crit. Care Med., December 15, 2004; 170(12): 1385 - 1385.
[Full Text] [PDF]


Home page
Eur Respir JHome page
M. Gaga
Fixed obstruction in severe asthma: not just a matter of time
Eur. Respir. J., July 1, 2004; 24(1): 8 - 10.
[Full Text] [PDF]


Home page
Eur Respir JHome page
D. Bumbacea, D. Campbell, L. Nguyen, D. Carr, P.J. Barnes, D. Robinson, and K.F. Chung
Parameters associated with persistent airflow obstruction in chronic severe asthma
Eur. Respir. J., July 1, 2004; 24(1): 122 - 128.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the European Respiratory Society.